Direxion Daily Pharmaceutical & Medical Bull 3X Shares (ARCA: PILL)

에 대한 최신 뉴스 Direxion Daily Pharmaceutical & Medical Bull 3X Shares (ARCA:PILL)

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Healthcare

Direxion

The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Dreyfus Govt Cash Man Ins

Goldman Sachs Fin Gov 465 Institut

Axsome Therapeutics, Inc

Viatris Inc.

Eli Lilly & Co.

Pfizer, Inc.

Catalent, Inc.

Gs Financial Square Treasury Instruments Fund

Tarsus Pharmaceuticals Inc

Jazz Pharmaceuticals Plc

Rpi International Holdings Lp P/P

Bristol-Myers Squibb Co.

Intra-Cellular Therapies Inc

Corcept Therapeutics Inc

Perrigo Company, Plc

Johnson & Johnson

Elanco Animal Health Inc.

Zoetis  Inc .

Donald Trump Shutterstock

News

Health Care

Markets

FTXH

iShares Dow Jones US Pharmaceuticals Index Fund

KURE

PILL

Merrill Lynch Pharmaceutical HOLDRs Trust

지난주 도널드 트럼프 대통령이 약가 인하 행정명령에 서명한 후, 전문가들은 제약사들이 가격 결정력이 떨어지는 가운데 마진 축소 가능성에 직면해 있는 가운데 처방약급여관리업체(PBM)가 가장 큰 타격을 받을 수 있다.

트럼프의 약가 인하 행정명령, PBM에 가장 큰 타격···CVS헬스, 시그나, 유나이티드헬스 주목

Eli Lilly and Co.

Equities

Government

ABBV

AMGN

GILD

REGN

도널드 트럼프 대통령은 수요일(9일) 상호관세를 90일 동안 일시 중단했지만, 나중에 집무실에서 기자들과의 대화에서 제약 회사들이 관세에 직면할 것이라고 확인했다. 

트럼프의 의약품 관세 확인...일라이릴리·애브비·리제네론·브리스톨 등 제약주 급락

PILLARSTONE CAPITAL REIT by Pillarstone Capital REIT

PILLARSTONE CPTL REIT PFD by Pillarstone Capital REIT

Pillar

Pillar Corp

Pillarstone Capital REIT

Pillarstone Capital REIT 9.50% PRF PERPETUAL USD 10 - Cls A9.50% PRF PERPETUAL USD 10 - Cls A

If scrolling your feed makes you feel like everyone's <a href="https://www.benzinga.com/money/are-you-rich">maxing out their 401(k)</a>, flipping houses, and buying gold bars "just for fun," you're not alone. But <a href="https://www.fidelity.com/learning-center/personal-finance/average-retirement-savings">Fidelity's latest retirement report</a> offers a much-needed reality check: most people aren't coasting into early retirement—they're just trying to stay on track.
Fidelity's Q4 2024 data offers a wide-angle look at more than 24.5 million participants across 26,700 corporate retirement plans. While it doesn't count savings in brokerage accounts, real estate, or that dusty jar of cash in your kitchen drawer, it's a solid snapshot of how Americans are preparing for retirement.
Don't Miss:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
Here's how average 401(k) and IRA balances actually stack up across the generations—and what that might say about your own retirement game.
<h2 class="wp-block-heading">Baby Boomers (Born 1946–1964)</h2>
<ul class="wp-block-list">
<li>Average 401(k): $249,300</li>
<li>Average IRA: $257,002</li>
<li>Total: $506,302</li>
</ul>
Boomers are clearly the furthest along—but even after <a href="https://www.benzinga.com/personal-finance/management/25/06/45752956/70-is-the-new-50-baby-boomers-are-being-told-to-keep-working-because-theyre-mentally-sharp-but-is-that-a-compliment-or-just-a-budget-fix">decades in the workforce</a>, most aren't looking at seven-figure balances. Their average savings rate is solid at 11.9%, plus 5% from employers. Still, with retirement possibly lasting 20–30 years, it's not exactly "leave-it-all-to-the-grandkids" money.
<h2 class="wp-block-heading">Gen X (Born 1965–1980)</h2>
<ul class="wp-block-list">
<li>Average 401(k): $192,300</li>
<li>Average IRA: $103,952</li>
<li>Total: $296,252 </li>
</ul>
Often labeled the "forgotten middle child" of the generational mix, Gen Xers are facing a now-or-never moment. Many are juggling college tuition, aging parents, and their own retirement dreams—and with just under $300,000 saved, the pressure is real.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
<h2 class="wp-block-heading">Millennials (Born 1981–1996)</h2>
<ul class="wp-block-list">
<li>Average 401(k): $67,300</li>
<li>Average IRA: $25,109</li>
<li>Total: $92,409</li>
</ul>
Despite being deep into their prime earning years, millennials are still catching up. Student debt, housing costs, and late career starts haven't helped. The good news? Their contribution rates are climbing—18.3% have gone all-in on Roth 401(k)s, and over 70% are using target date funds.
<h2 class="wp-block-heading">Gen Z (Born 1997–2012)</h2>
<ul class="wp-block-list">
<li>Average 401(k): $13,500</li>
<li>Average IRA: $6,672</li>
<li>Total: $20,172</li>
</ul>
Just getting started, Gen Z isn't breaking any records—yet. But don't sleep on them: 81.5% are investing in target date funds and nearly one in five is already contributing to a Roth 401(k). Plus, their average savings rate – 7.2% – shows they're thinking long-term earlier than most generations did.
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">What "On Track" Actually Looks Like</h2>
Feeling behind? Fidelity recommends saving 15% of your income annually – including employer match – to stay on track for retirement. And they offer this rule of thumb: aim to have 1x your salary saved by age 30, 3x by 40, 6x by 50, and 10x by 67.
While those targets may feel high—especially with inflation doing its thing—they serve as rough benchmarks for anyone wondering whether they're pacing with their peers.
<h2 class="wp-block-heading">Long-Term Savers Reap Long-Term Gains</h2>
One bright spot in the data: people who've stayed with the same employer and plan for 15+ years tend to see significantly higher balances. Why? Stability, consistency, and compound growth. It's less about timing the market and more about time in the market.
<a href="https://www.benzinga.com/money/smartasset">Retirement planning is less a race</a> and more a really long relay—one where you drop the baton, pick it up, and keep running. Whether you've got six figures saved or six months of rent, the key takeaway from Fidelity's data is this: it's not about being perfect—it's about being persistent.
And if you're still wondering how you stack up? You're already doing more than you think by paying attention.
Read Next: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Image: Shutterstock

Personal Finance

Is Your Retirement Nest Egg Above Average? Here's What People Have In Their 401(k) And IRA at Each Age

Alamos Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGI#NYSE">AGI</a>) has outperformed the market over the past 5 years by 14.59% on an annualized basis producing an average annual return of 27.9%. Currently, Alamos Gold has a market capitalization of $11.48 billion. 
Buying $100 In AGI: If an investor had bought $100 of AGI stock 5 years ago, it would be worth $340.92 today based on a price of $27.31 for AGI at the time of writing.
<h3>Alamos Gold's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749250821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Alamos Gold 5 Years Ago Would Be Worth Today

Republic Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSG#NYSE">RSG</a>) has outperformed the market over the past 5 years by 10.26% on an annualized basis producing an average annual return of 23.56%. Currently, Republic Services has a market capitalization of $79.05 billion. 
Buying $1000 In RSG: If an investor had bought $1000 of RSG stock 5 years ago, it would be worth $2,816.72 today based on a price of $252.97 for RSG at the time of writing.
<h3>Republic Services's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749249916_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Republic Services 5 Years Ago Would Be Worth This Much Today

All amounts in Canadian dollars unless specified otherwise
Cameco (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CCO#TSX">CCO</a>, NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) reports an expected increase of approximately $170 million (US) in our 49% equity share of Westinghouse Electric Company's (Westinghouse) 2025 second quarter and annual adjusted EBITDA. The expected increase is tied to Westinghouse's participation in the construction project for two nuclear reactors at the Dukovany power plant in the Czech Republic. This expected increase will be taken into consideration in determining the 2025 distribution payable by Westinghouse to Cameco.
In addition to the increase in adjusted EBITDA in 2025, we expect significant financial benefits for Westinghouse, as a subcontractor, over the term of the Dukovany construction project and related to the provision of the fuel fabrication services required for both reactors for a specified period. The outlook for Westinghouse's compound annual growth rate for adjusted EBITDA remains 6% to 10% over the next five years, excluding the impact of the expected $170 million (US) increase in its 2025 adjusted EBITDA.
Cameco owns a 49% interest in Westinghouse and its partner, Brookfield Renewable Partners, owns the remaining 51%.

TSX:CCO

Cameco Expects ~C$170M Boost To 2025 Adjusted EBITDA From Westinghouse Stake Due To Czech Nuclear Project

Shaquille O'Neal didn't just want an iPhone—he wanted the first one. Before the press, before the celebrities, before the world.
But even being a four-time NBA champion with global fame and a tech obsession couldn't get him ahead of Apple's notoriously secretive rollout in 2007. So what did he do? He pulled some strings, got Steve Jobs' personal number, and called—a lot.
"Stevie baby, it's Shaqy—can I get one of those iPhones?" he recalled asking. But Jobs wouldn't cave. "He said, ‘Shaq, I can't, I can't, I can't,'" O'Neal recounted speaking to <a href="https://youtu.be/ipAP2foYERc?si=OHbn03_aaFF46qHb">Mashable at SXSW in 2013</a>. "I got a lot of celebrities calling me… you gotta wait, Shaq."
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
This wasn't a one-time ask. Shaq was relentless. He wanted the first iPhone not just because it was cool, but because, as he put it, "when you're at the forefront of stuff, it's like bragging rights."
In a 2012 <a href="https://www.fastcompany.com/1824166/apple-makes-shaq-and-celebrities-everywhere-grovel-common-people/">interview with Fast Company</a>, he gave more context—and a little more heart. "I always wanted to be the one that's on the edge of the technological curve," he said. And when the iPhone was about to drop, he did what any certified tech nerd with a rolodex full of Silicon Valley contacts would do: he called in the favor. Over and over.
"The great Steve Jobs, rest in peace," Shaq said at the time. "When the iPhone was first coming out, I used to call him every other day. Can I please get one first? He never gave me one. He was a great guy."
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
The way Shaq tells it, you get the sense he wasn't even annoyed. In fact, he seemed to respect Jobs even more for sticking to his guns.
Shaq's not just a tech dabbler—he's a full-on enthusiast. "I'm a nerd, I'm a techie, I'm a geek," he proudly <a href="https://youtu.be/bWY6jsc0NcU?si=-4vSE6L2RJ2jSEHb">declared in a 2013 Bloomberg interview</a>. "All those terms we thought were funny are now in—and I'm proud to say I'm in."
And he meant it. In 2015, <a href="https://www.benzinga.com/startups/24/09/40677330/shaq-refused-to-pay-80-000-for-security-and-made-a-surprising-choice-he-invested-in-a-company-bezos">Shaq invested in Ring</a>, the smart doorbell company, after installing one himself and becoming a fan. He didn't stop at writing a check—he appeared in commercials and even went door-to-door helping install units in Georgia homes. When Amazon later acquired Ring in a reported $1 billion deal, Shaq's bragging rights became even more legit.
He <a href="https://www.forbes.com/sites/shlomosprung/2020/06/25/oura-nba-smart-rings-coronavirus-orlando-covid-pandemic-shaq-dell-benioff/">also backed Oura</a>, the smart ring that tracks sleep, recovery, and readiness scores. Because for a guy who's lived life at full throttle, it turns out the tech that monitors rest might be just as valuable as the tech that gets people hyped.
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
While basketball thrives on fierce competition, Shaq says the tech world operates on a completely different vibe. "In the basketball world, it's, ‘This is mine, and you can't have it,'" he explained. "But in tech, everybody's helping each other out. Kudos to the techie guys for everybody just having handshake deals." He went on to say there's more than enough innovation and opportunity to go around. "There's enough technology and enough dream space for everybody to survive," he added.
So no, Shaq never got that iPhone early. But he did get the last laugh—by diving headfirst into the tech world, not as a brand ambassador, but as a true geek with bragging rights of a different kind.
Because it's not just about being first. It's about being in. And on that front, <a href="https://www.benzinga.com/personal-finance/25/03/44380108/trust-me-im-reading-what-hes-doing-every-day-nba-legend-shaq-with-a-500-million-net-worth-swears-by-warren-buffetts-investing-wisdom">Shaq's already won</a>.
Read Next: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Image: Shutterstock

Shaq Wanted The First iPhone For Ultimate Bragging Rights—So He Called Steve Jobs: 'Stevie Baby, it's Shaqy…' But Jobs Told Him No

Descartes Systems Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) has outperformed the market over the past 15 years by 8.72% on an annualized basis producing an average annual return of 20.72%. Currently, Descartes Systems Group has a market capitalization of $8.77 billion. 
Buying $100 In DSGX: If an investor had bought $100 of DSGX stock 15 years ago, it would be worth $1,687.29 today based on a price of $102.25 for DSGX at the time of writing.
<h3>Descartes Systems Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749249017_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DSGX

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

CoStar Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>) has outperformed the market over the past 20 years by 7.24% on an annualized basis producing an average annual return of 15.58%. Currently, CoStar Group has a market capitalization of $33.12 billion. 
Buying $100 In CSGP: If an investor had bought $100 of CSGP stock 20 years ago, it would be worth $1,858.90 today based on a price of $78.52 for CSGP at the time of writing.
<h3>CoStar Group's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749248117_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CSGP

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

In the current market session, Greystone Housing Impact Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHI#NYSE">GHI</a>) share price is at $11.32, after a 4.39% decrease. Over the past month, the stock spiked by 2.93%, but over the past year, it actually fell by 20.68%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1749247242_0.png" alt="Past Year Chart" />

<h3>Greystone Housing Impact P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Greystone Housing Impact has a lower P/E than the aggregate P/E of 46.57 of the Financial Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749247242_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for Greystone Housing Impact

General

Tenaris To Launch The First $600M Tranche Of Its $1.2B Share Buyback Program

Reiterates that PENN and HG Vora Are Recommending the Same Two Highly-Qualified Nominees &ndash; Johnny Hartnett and Carlos Ruisanchez &ndash; for the Two Available Director Seats at the Upcoming Annual Meeting
PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>) (&quot;PENN&quot; or the &quot;Company&quot;) today made the following statement in response to the report issued today by Institutional Shareholder Services (&quot;ISS&quot;) related to the Company&#39;s 2025 Annual Meeting of Shareholders (the &quot;Annual Meeting&quot;) on June 17, 2025:
The ISS report confirms that two director seats are up for election at the 2025 Annual Meeting and that PENN and HG Vora have nominated and are recommending the same two highly-qualified candidates - Johnny Hartnett and Carlos Ruisanchez. ISS recognizes the open-mindedness with which PENN evaluated HG Vora&#39;s director candidates, noting: &quot;To its credit, the board appears to have given serious consideration to all three dissident nominees, and was open to accepting two of these nominees as its own.&quot;1 PENN encourages all shareholders to vote for Messrs. Hartnett and Ruisanchez for election and looks forward to welcoming them to the Board. Following the Annual Meeting, 75% of PENN&#39;s directors will have joined the Board since 2019.
In reaching its conclusions however, the ISS report fails to reflect a realistic view of William Clifford&#39;s candidacy. We remind shareholders that, during his time as PENN&#39;s CFO, Mr. Clifford advocated against key initiatives that were critical to succeeding in a competitive market. Following Mr. Clifford&#39;s departure in 2013 as PENN&#39;s CFO, these changes were implemented under the publicly announced P30 program and resulted in meaningful margin improvement. Further, during his interviews with PENN&#39;s Nominating and Corporate Governance Committee, Mr. Clifford demonstrated antiquated views of a rapidly changing industry, and the same posture of resistance to exploring value-generating solutions, which we believe would hinder constructive decision-making. PENN attempted multiple resolutions with HG Vora, but all of our resolution attempts were rejected. Given HG Vora&#39;s violation of its institutional waivers by multiple state gaming regulators, our ability to allow HG Vora to influence the governance of the Company beyond the evaluation of the nominees was expressly prohibited.
We appreciate the feedback and advice we have received from our shareholders in advance of this year&#39;s Annual Meeting. We want to assure shareholders that we understand and share their focus on ensuring that PENN&#39;s Board of Directors is optimally comprised to oversee the Company&#39;s execution on a strategic plan to drive shareholder value. The Board and management team remain committed to creating value for all shareholders and will continue to take actions in support of that objective.

Management

PENN

UPDATE: PENN Entertainment Responds To ISS Report; Reiterates That PENN And HG Vora Are Recommending The Same Two Nominees, Johnny Hartnett And Carlos Ruisanchez; Says Remains Committed To Creating Value For All Shareholders And Will Continue To Take Actions In Support Of That Objective

ADVB

Advanced Biomed Enters Purchase Agreement With Helena Global; To Issue And Sell Up To $25M In Common Stock

<a href="https://www.bloomberg.com/news/articles/2025-06-06/teton-capital-said-to-agitate-for-changes-at-atlantic-union-bank?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-06/teton-capital-said-to-agitate-for-changes-at-atlantic-union-bank?embedded-checkout=true</a>

'Teton Capital Said to Agitate for Changes at Atlantic Union Bank'- Bloomberg

PLTR climbs higher through the day after an alert from TradePulse in the morning
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/06205125/Screenshot-2025-06-06-at-4.49.54%E2%80%AFPM-995x1024.png" alt="" class="wp-image-14058" /></figure>
Palantir Tech. Inc. (PLTR) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:48 AM on June 6th, a significant trading signal occurred for Palantir Tech. Inc. (PLTR) as it demonstrated a Power Inflow at a price of $124.90. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Palantir's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Palantir's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for PLTR, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
The price at the time of the Power Inflow was $124.90. The returns on the High price ($128.13) and Close price ($127.72) after the Power Inflow are respectively 2.6% and 2.3%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your appetite for risk.
Past results are not indicative of future results

Technicals

Opinion

Signals

PLTR

Palantir Rises 2.6% After Key Trading Signal

Morningstar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MORN#NASDAQ">MORN</a>) has outperformed the market over the past 20 years by 22.83% on an annualized basis producing an average annual return of 31.17%. Currently, Morningstar has a market capitalization of $13.36 billion. 
Buying $100 In MORN: If an investor had bought $100 of MORN stock 20 years ago, it would be worth $23,251.58 today based on a price of $312.38 for MORN at the time of writing.
<h3>Morningstar's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749245429_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MORN

$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Offerings

PLUG

Plug Power Files For Resale From Time To Time Of 55M Shares Of Common Stock Offered By Selling Stockholder

ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBAI#NASDAQ">ZBAI</a>) reported quarterly losses of $(0.09) per share. This is a 12.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $250.00 thousand in sales this quarter. This is a 25.00 percent increase over sales of $200.00 thousand the same period last year.

Earnings

ZBAI

ATIF Holdings Q3 EPS $(0.09) Down From $(0.08) YoY, Sales $250.00K Up From $200.00K YoY

A feud between Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk and President Donald Trump could end Musk's ties with the White House — a development <a href="https://www.benzinga.com/interview/25/03/44539183/exclusive-tesla-protest-organizer-says-elon-musk-seems-to-have-purchased-the-american-government">welcomed by Tesla protestors</a>.
However, "the job is definitely not done,&#8221; volunteer organizer Adam Sheridan tells Benzinga.
<h3 class="wp-block-heading">Feud Comes Quicker Than Anticipated</h3>
"There was a time limit on this relationship between them," Sheridan says. 
Sheridan is a volunteer organizer with the Cooper River Indivisible <a href="https://www.cooperriverindivisible.org/" target="_blank" rel="noreferrer noopener">non-profit</a> that participates in Tesla Takedown protests.
Musk and Trump were on the same side for an election. Once that was over, there was an expiration day for their relationship, the Tesla protest organizer explained.
"I think it was predictable, but still <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45805173/musk-vs-trump-tesla-suffers-record-152b-one-day-crash-as-ceo-warns-tariffs-will-cause-a-recession">quicker [than expected],</a>&#8221; Sheridan adds.
Read Also: <a href="https://www.benzinga.com/news/politics/25/06/45800612/trump-says-musk-has-trump-derangement-syndrome-as-battle-over-bill-heats-up-had-a-great-relationship-dont-know-if-we-will-anymore">Trump Says Musk Has &#8216;Trump Derangement Syndrome&#8217; As Battle Over Bill Heats Up: &#8216;Had A Great Relationship… Don&#8217;t Know If We Will Anymore&#8217;</a>
<h3 class="wp-block-heading">Tesla Takedown Job Not Over</h3>
Sheridan said it's too early to tell if Musk is done with the White House. The Tesla protest organizer predicts Musk will still wield political influence. 
"I think he still has a lot of power,&#8221; Sheridan says. Musk&#8217;s ownership of X, he adds, allows him to control the narrative.
"[The] White House can't ignore him."
Sheridan said Trump is an emotional guy who governs on feelings, unlike other presidents who may not have gone after Musk or his companies.
"Trump really does have an ability to hurt Elon's businesses."
For example, Trump could be "detrimental" to Musk's businesses if he follows through on <a href="https://www.benzinga.com/news/space/25/06/45808621/after-threatening-to-scrap-dragon-spacecraft-amid-tussle-with-trump-musk-backs-down-following-social-media-plea-good-advice">cutting government contracts</a>, Sheridan added.
But getting Musk out of the White House was just 50% of Tesla Takedown&#8217;s goal.
Sheridan said there will be protests at Tesla dealerships on June 28, which is Musk's birthday. There will also be protests in Austin, Texas around Tesla's robotaxi demonstrations.
Moving on from physical protests at Tesla dealerships, Sheridan said attention may turn to economic efforts like getting pension funds to divest their Tesla stock. Sheridan also cautioned that Musk "still has a ton of power" and is threatening to launch and/or fund a third political party.
Sheridan said the goal is to continue to convince the billionaires that politics is not for them.
"Let the democratic process play out."
<h3 class="wp-block-heading">What's Next for Tesla</h3>
Sheridan warns that things could worsen for Tesla, considering Musk has fewer customers to sell to.
After catering to the left side of the political spectrum, Musk's behavior has alienated them and led to a hatred for Tesla. His campaigning catered to the MAGA (Make America Great Again) base of Trump supporters. However, if Musk is on the outs with Trump, he may be out of options. 
"Who's left? He's made enemies everywhere,&#8221; Sheridan said.
While not an analyst, Sheridan said Tesla stock price seems high given the constant flow of bad news <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45818240/tesla-stock-faces-demand-brand-issues-in-us-competition-in-china-analyst-lowers-delivery-estimates">and disappointing sales figures</a>.
Price Action: Tesla stock was up 3.7% to $295.14 on Friday. Tesla shares are down 14% over the last five days and down 22% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/44963440/tesla-takedown-says-protests-are-working-hitting-ev-company-where-it-hurts-the-companys-bottom-line">Tesla Takedown Says Protests Are Working: Hitting Where It Hurts, &#8216;The Company&#8217;s Bottom Line&#8217;</a></li>
</ul>
Image: Shutterstock

Politics

Exclusives

Interview

TSLA

EXCLUSIVE: Trump Can 'Hurt Elon's Businesses,' Says Tesla Protest Organizer — But At This Point 'Who's Left' To Buy?

Cyngn Donald Alvarez Steps Down As CFO And Board Member; Natalie Russell Appointed Interim CFO Effective June 6, 2025,

ROLR

High Roller Reveals Letter Of Non-Compliance With NYSE American Continued Listing Standards Received On On June 4, 2025

CACI International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) has outperformed the market over the past 15 years by 4.43% on an annualized basis producing an average annual return of 16.43%. Currently, CACI International has a market capitalization of $9.80 billion. 
Buying $100 In CACI: If an investor had bought $100 of CACI stock 15 years ago, it would be worth $977.08 today based on a price of $445.45 for CACI at the time of writing.
<h3>CACI International's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749244513_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACI

$100 Invested In CACI International 15 Years Ago Would Be Worth This Much Today

지난주 도널드 트럼프 대통령이 약가 인하 <a href="https://www.benzinga.com/general/health-care/25/05/45384935/trump-again-promises-lower-drug-prices-by-cutting-out-middlemen-like-unitedhealth-cvs-will-it-work-this-time" target="_blank" rel="noopener">행정명령</a>에 서명한 후, 전문가들은 제약사들이 가격 결정력이 떨어지는 가운데 마진 축소 가능성에 직면해 있는 가운데 처방약급여관리업체(PBM)가 가장 큰 타격을 받을 수 있다.
무슨 일 있었나: LPL 파이낸셜의 주식 리서치 책임자 토마스 쉽은 <a href="https://www.benzinga.com/news/25/05/45389750/trump-claims-drug-price-crackdown-could-slash-your-prescription-costs-by-59-but-will-big-pharma-fight-it-again" target="_blank" rel="noopener">제약사</a>들이 국내에서 가격 인하 압력에 직면하고 있다며, "가격 결정력을 약화시켜 마진을 압박할 가능성이 있으며, 제약사 주가에 상당한 역풍을 제공할 것"이라고 말했다.
그러나 그는 의약품 유통을 촉진하고 제약사와 협상을 통해 처방 비용을 낮추는 "중간자" 또는 PBM이 제약사로부터 리베이트를 받거나 "스프레드 프라이싱"과 같은 불투명한 가격 책정 관행으로 인해 조사를 받고 있다고 설명한다.
"PBM은 약국에 건강보험 가입자에게 청구하는 약값보다 적은 금액을 지불한다.&#8221;
트럼프가 서명한 또 다른 4월 15일 <a href="https://www.benzinga.com/markets/25/04/44866755/mark-cuban-says-this-trump-healthcare-order-could-save-hundreds-of-billions" target="_blank" rel="noopener">행정명령</a>은 PBM 수수료에 대한 투명성 강화를 촉구하고 이러한 중개업체의 역할을 재평가할 것을 요구했다.
CVS헬스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), 시그나 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>), 유나이티드헬스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)가 가장 큰 규모의 PBM 회사들이다.
또한 토마스 쉽은 PBM 비용 절감은 예상되지만 직접적인 가격 통제는 미국 중심의 제약사에게 장기적인 위험을 초래할 수 있다고 강조했다. 그는 투명성을 통해 PBM 마진 침식이 제조업체의 더 큰 가격 인하를 막을 수 있는지 여부를 알 수 있을 것이라고 했다.
"이러한 행정명령이 어떻게 시행될지에 대해서는 많은 의문이 남아 있지만, 초기 뉴스 흐름이 소화되고 나면 그 순효과는 PBM보다는 제약사에 덜 해로운 것으로 보인다.&#8221;
"그렇긴 하지만 미국인들이 의약품을 구매하는 방식을 바꾸는 데는 오랜 시간이 걸릴 것이다. 그 과정에서 소비자 직접 판매를 지원하려는 노력은 이를 주도하는 제조사와 유통을 위해 협력하는 제조사 모두를 지원할 것이다.&#8221;
왜 중요한가: 한편, 억만장자 투자자이자 &#8216;샤크 탱크&#8217;로 유명한 마크 큐반은 <a href="https://www.benzinga.com/personal-finance/25/04/44674382/mark-cuban-says-big-insurance-companies-and-pbms-control-healthcare-costs-everyone-has-to-kiss-their-a-and-accept-the-complications" target="_blank" rel="noopener">가격이 아닌 리베이트를 협상한다</a>고 설명하면서 엑스(X) 게시물에서 PBM을 "부정한 돈벌이"라고 불렀다.
"그들은 리베이트를 협상한다. 가격이 아니라 리베이트를 협상하는 것이다. 실제로 대형 PBM이 리베이트 협상의 95퍼센트 이상을 통제하고 있다. 대형 브랜드 제약사는 다른 제약사와 협상할 수 없다. 내 생각에 그것은 부정한 돈벌이다.&#8221;
4월 15일의 명령은 가격 책정의 투명성을 요구하지만, 큐반은 4조 9천억 달러에 달하는 의료비 지출의 30%가 대형 PBM이 만들어내는 가격 왜곡과 간접 보험회사에 기인한다고 강조한다.
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
One of the great lies the big PBM industry tells us is that they are needed to negotiate lower prices. 
It&#39;s a lie. They negotiate rebates. Not prices. In fact, the big PBMs control more than 95pct of the rebate negotiations. Big brand Pharma companies can&#39;t negotiate with…
&mdash; Mark Cuban (@mcuban) <a href="https://twitter.com/mcuban/status/1923880717420986860?ref_src=twsrc%5Etfw">May 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
2025년에 성과를 낸 위의 PBM 운영 회사는 다음과 같다.
<figure class="wp-block-table is-style-stripes">
<table class="has-fixed-layout">
<tbody>
<tr>
<td>주식</td>
<td>연초 대비 성과</td>
<td>1년 성과</td>
</tr>
<tr>
<td>CVS헬스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>)</td>
<td>41.41%</td>
<td>8.94%</td>
</tr>
<tr>
<td>시그나 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>)</td>
<td>16.92%</td>
<td>-3.73%</td>
</tr>
<tr>
<td>유나이티드헬스 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td>-42.14%</td>
<td>-43.56%</td>
</tr>
</tbody>
</table>
</figure>
투자자들이 고려할 수 있는 몇 가지 제약 관련 ETF는 다음과 같다.
<figure class="wp-block-table is-style-stripes">
<table class="has-fixed-layout">
<tbody>
<tr>
<td>제약 ETF</td>
<td>연초 대비 성과</td>
<td>1년 성과</td>
</tr>
<tr>
<td>VanEck Pharmaceutical ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPH#NASDAQ">PPH</a>)</td>
<td>-0.28%</td>
<td>-4.66%</td>
</tr>
<tr>
<td>iShares US Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHE#NYSE">IHE</a>)</td>
<td>-1.20%</td>
<td>-2.03%</td>
</tr>
<tr>
<td>Invesco Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJP#NYSE">PJP</a>)</td>
<td>-3.45%</td>
<td>-0.83%</td>
</tr>
<tr>
<td>SPDR S&amp;P Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPH#NYSE">XPH</a>)</td>
<td>-4.83%</td>
<td>-1.70%</td>
</tr>
<tr>
<td>KraneShares MSCI All China Health Care Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KURE#NYSE">KURE</a>)</td>
<td>11.10%</td>
<td>1.65%</td>
</tr>
<tr>
<td>First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXH#NASDAQ">FTXH</a>)</td>
<td>-6.51%</td>
<td>-6.89%</td>
</tr>
<tr>
<td>Direxion Daily Pharmaceutical &amp; Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PILL#NYSE">PILL</a>)</td>
<td>-23.63%</td>
<td>-24.07%</td>
</tr>
</tbody>
</table>
</figure>
SPDR S&amp;P 500 ETF 트러스트 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)와 인베스코 QQQ 트러스트 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)는 각각 S&amp;P 500 지수와 나스닥 100 지수를 추적하며 지난 금요일에 상승 마감했다. SPY는 0.63% 상승하여 594.20달러, QQQ는 0.44% 상승하여 521.51달러에 마감했다.
사진 제공: Rawpixel.com / Shutterstock.com
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

도널드 트럼프 대통령은 수요일(9일) 상호관세를 90일 동안 일시 중단했지만, 나중에 집무실에서 기자들과의 대화에서 제약 회사들이 관세에 직면할 것이라고 확인했다.
무슨 일 있었나: 제약주 랠리는 목요일 시장이 하락세로 전환되면서 단기간에 그쳤다. 한 기자가 트럼프 대통령에게 제약 주식에 관세를 부과할 것이냐는 질문을 하자, 트럼프 대통령은 이렇게 답했다. "그렇게 할 것이다. 왜냐하면 우리는 그들이 다시 돌아오기를 원하기 때문이다.&#8221;
"코로나19를 겪으면서 우리는 미국에서 의약품을 만들지 않는다는 사실을 깨달았다. 그래서 큰 깨달음을 얻었다.&#8221;
트럼프는 코로나19의 비상 사태를 언급하며 제약 회사들이 미국에서 의약품을 생산하기를 원한다고 말했다.
"우리는 약을 구하기 위해 중국으로 가야 했고, 다른 곳으로 가야 했고, 약을 구하지 못했다. 우리가 그들이 떠나도록 내버려 두었기 때문이다&#8230;제약 회사에 관세를 부과할 것이고, 모두 돌아오고 싶어 할 것이다.&#8221;
트럼프의 관세 확정 이후 목요일 제약주는 급락했다.
<figure class="wp-block-table is-style-stripes">
<table style="overflow:auto; height: 90px; display: block;">
<tbody>
<tr>
<td>제약주</td>
<td>목요일 주가 변동</td>
<td>2025년 변동</td>
<td>지난 1년 변동</td>
</tr>
<tr>
<td>일라이 릴리 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>)</td>
<td>-4.35%</td>
<td>-7.35%</td>
<td>-5.09%</td>
</tr>
<tr>
<td>애브비 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>)</td>
<td>-3.14%</td>
<td>-2.92%</td>
<td>3.99%</td>
</tr>
<tr>
<td>브리스톨 마이어스 스퀴브 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)</td>
<td>-6.10%</td>
<td>-11.15%</td>
<td>2.73%</td>
</tr>
<tr>
<td>리제네론 파마슈티컬스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>)</td>
<td>-5.26%</td>
<td>-23.60%</td>
<td>-40.63%</td>
</tr>
<tr>
<td>화이자 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)</td>
<td>-3.87%</td>
<td>-18.87%</td>
<td>-18.03%</td>
</tr>
<tr>
<td>길리어드 사이언스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</td>
<td>-3.66%</td>
<td>10.36%</td>
<td>47.71%</td>
</tr>
<tr>
<td>머크 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</td>
<td>-5.32%</td>
<td>-21.80%</td>
<td>-38.53%</td>
</tr>
<tr>
<td>암젠 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>)</td>
<td>-3.33%</td>
<td>8.54%</td>
<td>4.23%</td>
</tr>
<tr>
<td>존슨앤드본슨 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)</td>
<td>-1.51%</td>
<td>3.24%</td>
<td>-0.07%</td>
</tr>
</tbody>
</table>
</figure>
왜 중요한가: 90일간의 상호 관세 유예에도 불구하고 10%의 글로벌 기본 관세와 125%의 중국 관세, 그리고 철강 및 알루미늄, 자동차, 자동차 부품에 대한 25%의 부문별 관세는 그대로 유지된다. 여기에 더해 트럼프 대통령은 곧 제약사에 대한 관세를 발표할 수 있음을 시사했다.
영향을 받을 수 있는 제약 산업 관련 상장지수펀드는 다음과 같다.
<figure class="wp-block-table is-style-stripes">
<table style="overflow:auto; height: 90px; display: block;">
<tbody>
<tr>
<td>제약 ETF</td>
<td>2025년 변동</td>
<td>지난 1년 변동</td>
</tr>
<tr>
<td>VanEck Pharmaceutical ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPH#NASDAQ">PPH</a>)</td>
<td>-7.02%</td>
<td>-7.51%</td>
</tr>
<tr>
<td>iShares US Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHE#NYSE">IHE</a>)</td>
<td>-7.04%</td>
<td>-6.08%</td>
</tr>
<tr>
<td>Invesco Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJP#NYSE">PJP</a>)</td>
<td>-10.13%</td>
<td>-4.37%</td>
</tr>
<tr>
<td>SPDR S&amp;P Pharmaceuticals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPH#NYSE">XPH</a>)</td>
<td>-14.05%</td>
<td>-11.45%</td>
</tr>
<tr>
<td>KraneShares MSCI All China Health Care Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KURE#NYSE">KURE</a>)</td>
<td>2.88%</td>
<td>0.35%</td>
</tr>
<tr>
<td>First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXH#NASDAQ">FTXH</a>)</td>
<td>-11.54%</td>
<td>-10.18%</td>
</tr>
<tr>
<td>Direxion Daily Pharmaceutical &amp; Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PILL#NYSE">PILL</a>)</td>
<td>-41.35%</td>
<td>-43.86%</td>
</tr>
</tbody>
</table>
</figure>
가격 움직임: 목요일 하락 후 수요일 반등에 이어 나스닥 100 지수는 전고점인 22,222.61포인트보다 17.46% 하락했다. S&amp;P 500 지수는 전고점인 6,147.43포인트 대비 14.31% 하락했고, 다우존스 지수는 52주 최고치인 45,073.63포인트 대비 12.16% 하락했다.
각각 S&amp;P 500 지수와 나스닥 100 지수를 추종하는 SPDR S&amp;P 500 ETF 신탁(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)과 인베스코 QQQ 신탁 ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)는 목요일에 하락 마감했다. SPY는 524.58달러로 4.38% 하락했고, QQQ는 446.18달러로 4.25% 하락했다.
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

뉴스

에 대한 최신 뉴스 Direxion Daily Pharmaceutical & Medical Bull 3X Shares (ARCA:PILL)

월요일, 5월 19, 2025

금요일, 4월 11, 2025

뉴스

파트너 / 기고자

벤징가 글로벌